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WU polyomavirus was detected in nasopharyngeal 
aspirates in 2 (2.5%) of 79 children with respiratory infec-
tions (both infected with respiratory syncytial virus) and in 5 
(6.4%) of 78 asymptomatic children during the same winter 
season in Canada. The strains were closely related to Aus-
tralian and American viruses based on analysis of large T 
antigen (TAg) and VP2 genes. The pathogenic role of WU 
virus is still uncertain.
P
olyomaviruses are nonenveloped viruses that have an 
icosahedral capsid containing a small, circular, double-
stranded DNA genome (1). These viruses have been iden-
tiﬁ  ed in a variety of mammals and birds worldwide, and 
the most studied polyomavirus species infecting animals 
are the mouse polyomavirus (2) and the simian vacuolating 
(SV40) virus (3). In 1971, 2 human polyomavirus species 
named BK and JC viruses, respectively, were ﬁ  rst isolated 
from the urine of a kidney allograft recipient with chronic 
pyelonephritis and advanced renal failure (4) and from 
the brain of a patient with progressive multifocal leuko-
encephalopathy (5). Recently, 2 new human polyomavirus 
members were described. The KI virus was identiﬁ  ed in na-
sopharyngeal aspirates (NPA) and feces from patients with 
respiratory tract infections in Sweden (6). Also, Gaynor and 
colleagues (7) reported the detection and molecular charac-
terization of the WU virus in clinical respiratory samples 
from patients with acute respiratory tract infections (ARTI). 
Although the pathogenesis of BK and JC viruses has been 
clearly established, the role of the KI and WU viruses as 
respiratory pathogens has yet to be demonstrated. In this 
article, we report on the molecular detection and character-
ization of WU viruses in NPA from hospitalized children 
with or without respiratory tract infections.
The Study
We tested 157 NPA specimens obtained from a case-
control study on the incidence of respiratory viral agents, 
the results of which have been partly reported by our group 
(8). Participants were children <3 years of age who were 
hospitalized from December 2002 through April 2003 at 
Laval University Hospital Center in Quebec City, Quebec, 
Canada. Case-patients were children admitted for ARTI 
(mostly bronchiolitis, pneumonitis, and laryngotracheo-
bronchitis) who had an NPA collected as part of the in-
vestigation of their illness. A research nurse administered 
a speciﬁ  c questionnaire at admission in the presence of the 
parents. At the end of the hospitalization, the children’s 
charts were reviewed to collect clinical and laboratory data. 
Eligible controls were children hospitalized during the 
same period for any elective surgery. These children had no 
concomitant respiratory symptoms or fever at admission, 
although they might have had an ARTI in the weeks before 
hospitalization. The study nurse obtained a signed consent 
from parents and a NPA was obtained during surgery. The 
original study was approved by the ethics committee of the 
Center Hospitalier Universitaire de Quebec.
NPA samples (200 μL) were used for nucleic acid ex-
traction using the QIAamp viral RNA Mini Kit (QIAGEN, 
Inc., Mississauga, Ontario, Canada), which has been shown 
to recover both RNA and DNA. These specimens were pre-
viously analyzed by using a multiplex real-time RT-PCR 
assay for inﬂ  uenza A and B viruses, human respiratory syn-
cytial virus (hRSV), and human metapneumovirus (hMPV) 
(8). For symptomatic children, viral cultures and antigen 
detection assays were performed at the treating physician’s 
request. The specimens were frozen at –80°C during the 4 
years before PCR studies began for WU polyomavirus. All 
specimens were ﬁ  rst tested for WU virus DNA by using 
primers AG0048 and AG0049, which allowed the ampli-
ﬁ  cation of a 244-bp product in the 3′ end of the large T 
antigen (TAg) region (7). A plasmid containing the partial 
WU genomic DNA from the original Australian virus (B0 
strain) served as the positive control in each PCR batch (7). 
For WU-positive samples with the TAg primers, a conﬁ  r-
matory PCR assay was performed with primers AG0044 
and AG0045 to amplify a 250-bp fragment from the VP2 
region (7). PCR products were analyzed by agarose gel 
electrophoresis. Positive amplicons were subsequently pu-
riﬁ  ed and sequenced by using the respective PCR primers.
The Canadian WU VP2 sequences were compared 
with those of 18 WU viruses that originated in Brisbane, 
Queensland, Australia, and St Louis, Missouri, USA (7). 
For this purpose, multiple nucleotide sequence alignments 
were performed by using the ClustalW program followed 
by phylogenetic analyses, which were conducted with the 
MEGA version 3.1 software using the neighbor-joining al-
gorithm with Kimura-2 parameters (9).
By using the PCR assay with primers targeting the 
large TAg, WU sequences were detected in 2 (2.53%) of 
79 symptomatic children (the 2 children were 13 months 
old) and in 5 (6.41%) of 78 asymptomatic children, 13–24 
months of age (mean age 20 months) (Table). Symptom-
atic children had a diagnosis of bronchiolitis (patient 1) 
and pneumonitis (patient 2) and were both coinfected with 
hRSV. In contrast, no other viruses were detected in the as-
ymptomatic children who underwent elective surgery. The 
duration of hospitalization for the 2 symptomatic children 
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with dual WU/hRSV infection (3 and 4 days) was similar 
to that of 120 children with single hRSV infection (median: 
4 days). By using the PCR assay with primers targeting the 
VP2 region, WU sequences were detected in 4/7 previously 
positive children, including 1 symptomatic (patient 1) and 
3 asymptomatic (patients 3, 5 and 6) patients (Table). The 
7 large TAg nt sequences of Canadian WU viruses were 
100% identical and had 99.5% identity to the WU sequence 
contained in the control plasmid from Australia (data not 
shown). In addition, 100% identity was found between 
the VP2 nt sequences of the 4 Canadian WU viruses (data 
not shown). The latter also shared 100% identity with the 
most frequently observed WU genotypes (represented 
by previously-reported WU strains B9, S6, B28, B37, 
B22, B24, B35, B10, B1, and B17 [GenBank accession 
numbers: EF444592, EF444593, EF444590, EF444589, 
EF444588, EF444587, EF444586, EF444584, EF444583 
and EF444582, respectively]) and, obviously, clustered to-
gether in the phylogenetic tree (Figure).
Conclusions
In this study, we report for the ﬁ  rst time, to our knowl-
edge, the presence of the newly described WU polyomavi-
rus in Canadian children. We found that more asymptom-
atic (6.4%) than symptomatic (2.5%) children shed viral 
DNA in their respiratory tract. The WU polyomavirus was 
previously identiﬁ  ed in respiratory tract samples from Aus-
tralian and American patients, which suggests its world-
wide distribution. Efforts to culture this new virus by using 
PCR-positive respiratory specimens have thus far been un-
successful (D. Wang, unpub. data).
The 7 sequences of the large TAg region and the 4 se-
quences of the VP2 region from the Canadian WU strains 
displayed no sequence variations. This could be due to the 
short size of these PCR products (244 and 250 bp, respec-
tively) and the stability of this double-stranded DNA ge-
nome. A similar ﬁ  nding of limited sequence variation was 
reported in the previous molecular study performed with 
Australian and American WU strains (7). Indeed, 4 Ca-
nadian WU strains had 100% nucleotide identity with 10 
strains selected from these cohorts when VP2 sequences 
were compared (Figure).
Since we aimed at evaluating the possible contribution 
of the WU polyomavirus in respiratory tract infections of 
children, we tested NPA samples from symptomatic and 
asymptomatic subjects of the same age (<3 years) that were 
collected during the same winter period at the same institu-
tion. The WU virus was detected in 5 asymptomatic chil-
dren at the time of an elective surgery and in 2 symptom-
atic children (bronchiolitis and pneumonitis) who were also 
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Table. Clinical data from 7 WU polyomavirus–infected children, Canada, 2003* 
Patient no. Sex Age, mo
Date sample 
collected Sample type
PCR for WU virus 
LTAg/VP2 Diagnosis Copathogen
1 F 13 Feb 13 NPA +/+ Bronchiolitis hRSV
2 M 13 Mar 5 NPA +/– Pneumonitis hRSV
3 F 13 Feb 24 NPA +/+ None† None
4 M 20 Mar 13 NPA +/– None† None
5 F 24 Mar 17 NPA +/+ None† None
6 M 19 Mar 31 NPA +/+ None† None
7 F 24 Apr 1 NPA +/– None† None
*NPA, nasopharyngeal aspirates; hRSV, human respiratory syncytial virus. 
†No fever or respiratory symptoms at the time of elective surgery. 
Figure. Phylogenetic analysis of Canadian WU polyomavirus 
strains CanWUT9–2003, CanWUT38–2003, CanWUC40–2003 
and CanWUT52–2003 (shown in boldface), based on nucleotide 
sequences of the VP2 region. Multiple nucleotide sequence 
alignments were performed by using the ClustalW program and 
a phylogenetic tree was constructed with the MEGA 3.1 software 
using the neighbor-joining algorithm with Kimura-2 parameters 
(9). The analysis included WU strains previously identiﬁ  ed  from 
Australian and American cohorts (7) i.e., B9, S6, B28, B37, B22, 
B24, B35, B10, B1, B17, B0, B12, B20, B14, B34, B21, B3, and 
B2 (GenBank accession nos.: EF444592, EF444593, EF444590, 
EF444589, EF444588, EF444587, EF444586, EF444584, 
EF444583, EF444582, EF-444555, EF444557, EF444561, 
EF444562, EF444572, EF444585, EF444567, and EF444591, 
respectively).WU Polyomavirus in Children, Canada
infected with hRSV. A high rate of coinfection was also 
noted in the Australian cohort (68%) and in the American 
cohort (100%) (7). Notably, similar ﬁ  ndings were obtained 
in a study on the related KI polyomavirus in which another 
viral pathogen was found in 5/6 KI-positive samples (6). 
By analogy with other human polyomaviruses (BK and 
JC), WU and KI possibly could establish a latent infection 
with subsequent asymptomatic reactivation; further studies 
are needed for conﬁ  rmation. The presence of WU virus in 
the control children could also represent prolonged shed-
ding from a prior respiratory tract infection. In conclusion, 
although this study conﬁ  rmed the presence of the WU poly-
omavirus in NPA samples from Canadian children and sug-
gests that its distribution is worldwide, its role in respira-
tory tract diseases of children remains undetermined.
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